Quantcast

Latest Brain tumor Stories

2014-10-29 12:29:43

Proton beam radiation does not cause the serious side effects associated with conventional radiation for children with brain and spinal cancers. HOUSTON, Oct. 29, 2014 /PRNewswire-USNewswire/ -- The number of children suffering from brain and spinal cancers who were treated with an advanced form of radiation at proton therapy centers in the U.S. rose 36% since 2010, according to a study released on October 28, 2014 at the first annual meeting of the Particle Therapy Cooperative Group...

2014-10-29 08:33:20

Procedure was accomplished using the new Edge(TM) radiosurgery system for the precise, efficient, non-invasive treatment of cancer MIAMI, Oct. 29, 2014 /PRNewswire/ -- A 71-year-old man with a tumor encroaching on his spinal cord was among the first people to receive treatment using a new Edge(TM) radiosurgery system, recently installed at Innovative Cancer Institute in Miami. A new radiosurgery platform from Varian Medical Systems (NYSE: VAR), the Edge offers doctors a fast,...

2014-10-29 08:32:56

The supplement is intended to provide an overview of available knowledge regarding the use of NovoTTF Therapy for the treatment of recurrent glioblastoma, as well as its development for the treatment of lung cancer ST. HELIER, Jersey, Oct. 29, 2014 /PRNewswire/ -- Novocure, a commercial stage oncology company, announced today the publication of four articles on NovoTTF Therapy in a Seminars in Oncology supplement. The supplement includes an article describing the findings from...

2014-10-29 08:31:56

LOS ANGELES, Oct. 29, 2014 /PRNewswire/ -- CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that a paper, titled "Therapeutic Efficacy of Aldoxorubicin in an Intracranial Xenograft Mouse Model of Human Glioblastoma," has been published online in Neoplasia (Volume 16, Issue 10). The paper amplifies previously reported positive preclinical data that demonstrated that aldoxorubicin significantly increased survival...

2014-10-28 08:36:43

HEIDELBERG, Germany, Oct. 28, 2014 /PRNewswire/ -- Apogenix, a clinical stage biopharmaceutical company, announced today that the final data of the completed phase II clinical trial with APG101 in recurrent glioblastoma has been published in the peer-reviewed journal Clinical Cancer Research. The data demonstrates that treatment with APG101, a CD95 ligand-binding fusion protein, in combination with radiotherapy is an innovative concept that has shown clinical superiority in all study...

2014-10-27 12:27:40

ASHEVILLE, N.C., Oct. 27, 2014 /PRNewswire-USNewswire/ -- The Pediatric Brain Tumor Foundation's Starry Night 8.5K is an evening walk/run to help kids battling one of the deadliest forms of childhood cancer. Starry Night Los Angeles is coming to Griffith Park on Saturday, Nov. 22. More than 28,000 children in the United States are living with a brain tumor. Each of Starry Night's 28,000 steps will shine light on these Stars while raising funds for lifesaving medical research and...

2014-10-24 20:22:05

HOUSTON, Oct. 24, 2014 /PRNewswire/ -- Burzynski Research Institute, Inc. (BRI) announced today that the U.S. Food and Drug Administration (FDA) has given the company permission to conduct an open-label study of Antineoplastons A10 and AS2-1 in patients > 3 months of age with a diffuse intrinsic brainstem glioma (DIPG). Study subjects will be placed in one of five treatment groups based on their age and whether or not they have received prior treatment for DIPG. The primary study...

2014-10-22 23:06:03

Six new members elected at ABTA annual meeting Chicago, IL (PRWEB) October 22, 2014 The American Brain Tumor Association (ABTA) – the first and now only organization to fund brain tumor research and provide education and information on all tumor types for all ages – has elected six new members to its Board of Directors as well as the full slate of officers at its recent annual meeting in Chicago. “It is a privilege to welcome new members to the ABTA’s Board of Directors who...

2014-10-21 12:32:26

Cancer Survivor Shares Personal Story During National Breast Cancer Awareness Month RENO, Nev., Oct. 21, 2014 /PRNewswire/ -- As the second-most diagnosed cancer in women in the U.S., breast cancer impacts the lives of many. Debbie Black, a Nevada resident, is among those whose life has been dramatically impacted by the disease. http://photos.prnewswire.com/prnvar/20141020/153187 Initially diagnosed with stage II breast cancer at the age of 30, Black underwent aggressive...

2014-10-20 23:02:05

In-demand research report “Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM” elaborated by GBI Research is now available at MarketPublishers.com. According to the study, the APAC glioblastoma multiforme therapeutics market is predicted to reach USD 105.8 million by 2020. London, UK (PRWEB) October 20, 2014 The glioblastoma multiforme (GBM) therapeutics market in the APAC...


Word of the Day
maffling
  • To stammer.
  • Present participle of maffle, to stammer.
  • A simpleton.
The word 'maffle' may come from a Dutch word meaning 'to move the jaws' or a French word meaning 'having large cheeks'.